Payment overview · 2025
General Payments
$173.16
10 reported records · 6 companies
Healthcare provider profile · identity verified
John Warren
Allopathic & Osteopathic Physicians|Internal Medicine · TUSCALOOSA, AL · NPI 1013120104
Verified facts
What the public records show
CMS Open Payments records show John Warren received $173.16 in general payments during 2025 across 10 reported records.
PFIZER INC. accounted for 33.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Mounjaro, Rexulti.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 225 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 204 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 156 claims for Trulicity by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Rexulti by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 148 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Rybelsus by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 621 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $57.88 | 33.4% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $35.11 | 20.3% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $31.64 | 18.3% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $18.46 | 10.7% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $15.54 | 9.0% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $14.53 | 8.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $173.16 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $57.88 | 3 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $35.11 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $31.64 | 2 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $25.52 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $18.46 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $15.54 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $14.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 621 | exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 204 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 35 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
225 | 38 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
204 | 44 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
156 | 25 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
35 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
148 | 29 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
621 | 84 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
33 | 33 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1212 | 233 |
| Amlodipine Besylate | Amlodipine Besylate | 1114 | 262 |
| Atorvastatin Calcium | Atorvastatin Calcium | 920 | 210 |
| Gabapentin | Gabapentin | 794 | 147 |
| Losartan Potassium | Losartan Potassium | 749 | 187 |
| Pantoprazole Sodium | Pantoprazole Sodium | 692 | 174 |
| Simvastatin | Simvastatin | 628 | 140 |
| Eliquis | Apixaban | 621 | 84 |
| Omeprazole | Omeprazole | 615 | 158 |
| Furosemide | Furosemide | 572 | 135 |
| Metoprolol Succinate | Metoprolol Succinate | 440 | 105 |
| Escitalopram Oxalate | Escitalopram Oxalate | 435 | 106 |
| Trazodone Hcl | Trazodone Hcl | 421 | 87 |
| Metformin Hcl | Metformin Hcl | 417 | 97 |
| Lisinopril | Lisinopril | 397 | 89 |
| Potassium Chloride | Potassium Chloride | 391 | 76 |
| Famotidine | Famotidine | 370 | 77 |
| Meloxicam | Meloxicam | 365 | 91 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 357 | 68 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 339 | 176 |
| Alprazolam | Alprazolam | 335 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 330 | 71 |
| Hydrochlorothiazide | Hydrochlorothiazide | 329 | 72 |
| Tramadol Hcl | Tramadol Hcl | 324 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 307 | 79 |
| Cefuroxime | Cefuroxime Axetil | 302 | 217 |
| Montelukast Sodium | Montelukast Sodium | 291 | 86 |
| Carvedilol | Carvedilol | 283 | 54 |
| Donepezil Hcl | Donepezil Hcl | 282 | 60 |
| Ezetimibe | Ezetimibe | 280 | 70 |
| Allopurinol | Allopurinol | 268 | 55 |
| Buspirone Hcl | Buspirone Hcl | 268 | 55 |
| Pravastatin Sodium | Pravastatin Sodium | 264 | 59 |
| Clopidogrel | Clopidogrel Bisulfate | 263 | 63 |
| Memantine Hcl | Memantine Hcl | 260 | 44 |
| Temazepam | Temazepam | 259 | 40 |
| Sertraline Hcl | Sertraline Hcl | 232 | 54 |
| Duloxetine Hcl | Duloxetine Hcl | 231 | 56 |
| Jardiance | Empagliflozin | 225 | 38 |
| Diclofenac Sodium | Diclofenac Sodium | 224 | 84 |
| Methocarbamol | Methocarbamol | 221 | 73 |
| Mirtazapine | Mirtazapine | 221 | 53 |
| Mounjaro | Tirzepatide | 204 | 44 |
| Zolpidem Tartrate | Zolpidem Tartrate | 198 | 25 |
| Celecoxib | Celecoxib | 195 | 52 |
| Prednisone | Prednisone | 195 | 144 |
| Fluticasone Propionate | Fluticasone Propionate | 184 | 69 |
| Hydralazine Hcl | Hydralazine Hcl | 173 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 170 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 163 | 43 |
| Citalopram Hbr | Citalopram Hydrobromide | 161 | 29 |
| Chlorthalidone | Chlorthalidone | 159 | 46 |
| Trulicity | Dulaglutide | 156 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 148 | 43 |
| Ozempic | Semaglutide | 148 | 29 |
| Fenofibrate | Fenofibrate | 142 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 142 | 32 |
| Clonazepam | Clonazepam | 135 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 133 | 24 |
| Doxycycline Hyclate | Doxycycline Hyclate | 131 | 109 |
| Valsartan | Valsartan | 128 | 30 |
| Lorazepam | Lorazepam | 127 | 23 |
| Atenolol | Atenolol | 126 | 25 |
| Telmisartan | Telmisartan | 119 | 26 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 117 | 33 |
| Ondansetron Hcl | Ondansetron Hcl | 117 | 60 |
| Glimepiride | Glimepiride | 115 | 31 |
| Divalproex Sodium | Divalproex Sodium | 107 | 26 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 105 | 21 |
| Clonidine Hcl | Clonidine Hcl | 105 | 24 |
| Xarelto | Rivaroxaban | 100 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 97 | 16 |
| Spironolactone | Spironolactone | 94 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 93 | 23 |
| Warfarin Sodium | Warfarin Sodium | 93 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 92 | 37 |
| Glipizide | Glipizide | 92 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 92 | 18 |
| Humalog Kwikpen U-100 | Insulin Lispro | 87 | 15 |
| Sucralfate | Sucralfate | 82 | 29 |
| Amitriptyline Hcl | Amitriptyline Hcl | 81 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 81 | 22 |
| Baclofen | Baclofen | 80 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 79 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 78 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 78 | 25 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 75 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 74 | 17 |
| Pregabalin | Pregabalin | 71 | 13 |
| Bumetanide | Bumetanide | 70 | 16 |
| Eszopiclone | Eszopiclone | 70 | 11 |
| Glipizide Er | Glipizide | 70 | 17 |
| Meclizine Hcl | Meclizine Hcl | 70 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 70 | 14 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 66 | suppressed |
| Levetiracetam | Levetiracetam | 66 | suppressed |
| Novolog | Insulin Aspart | 65 | 17 |
| Valacyclovir | Valacyclovir Hcl | 65 | 31 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 64 | 14 |
| Methylprednisolone | Methylprednisolone | 64 | 44 |
| Myrbetriq | Mirabegron | 64 | 20 |
| Finasteride | Finasteride | 63 | 16 |
| Tradjenta | Linagliptin | 63 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 60 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 58 | 26 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 14 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 57 | 17 |
| Mupirocin | Mupirocin | 56 | 41 |
| Breo Ellipta | Fluticasone/Vilanterol | 55 | 12 |
| Digoxin | Digoxin | 55 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 55 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 55 | 52 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 55 | 15 |
| Risperidone | Risperidone | 55 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 54 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 53 | 32 |
| Fenofibrate | Fenofibrate Nanocrystallized | 52 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 52 | suppressed |
| Lansoprazole | Lansoprazole | 51 | suppressed |
| Humalog | Insulin Lispro | 50 | suppressed |
| Nifedipine Er | Nifedipine | 50 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 50 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 49 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 48 | 20 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 47 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 46 | suppressed |
| Fluconazole | Fluconazole | 45 | 32 |
| Ramipril | Ramipril | 44 | 12 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 44 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 43 | 35 |
| Bupropion Xl | Bupropion Hcl | 42 | 11 |
| Naproxen | Naproxen | 42 | 20 |
| Nystatin | Nystatin | 41 | 27 |
| Rivastigmine | Rivastigmine Tartrate | 40 | suppressed |
| Synthroid | Levothyroxine Sodium | 40 | 12 |
| Alendronate Sodium | Alendronate Sodium | 38 | 17 |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 38 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 37 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 36 | suppressed |
| Olanzapine | Olanzapine | 36 | suppressed |
| Xifaxan | Rifaximin | 36 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 35 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 35 | 11 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 35 | suppressed |
| Rexulti | Brexpiprazole | 35 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 34 | suppressed |
| Linzess | Linaclotide | 34 | 11 |
| Memantine Hcl Er | Memantine Hcl | 34 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 34 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 33 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 33 | 33 |
| Primidone | Primidone | 33 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 32 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Latanoprost | Latanoprost | 32 | suppressed |
| Lovastatin | Lovastatin | 32 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 31 | 31 |
| Felodipine Er | Felodipine | 30 | suppressed |
| Irbesartan | Irbesartan | 30 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 30 | suppressed |
| Entresto | Sacubitril/Valsartan | 29 | suppressed |
| Glyburide | Glyburide | 29 | suppressed |
| Ibuprofen | Ibuprofen | 29 | 14 |
| Levemir Flexpen | Insulin Detemir | 29 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 29 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 28 | suppressed |
| Dutasteride | Dutasteride | 28 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 28 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 12 |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 23 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 26 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 16 |
| Doxepin Hcl | Doxepin Hcl | 25 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 25 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 25 | 17 |
| Jantoven | Warfarin Sodium | 25 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 25 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 25 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 24 | suppressed |
| Calcitriol | Calcitriol | 24 | suppressed |
| Estradiol | Estradiol | 24 | suppressed |
| Invokamet Xr | Canagliflozin/Metformin Hcl | 24 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 17 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 24 | suppressed |
| Premarin | Estrogens, Conjugated | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 23 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 23 | suppressed |
| Torsemide | Torsemide | 23 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 22 | suppressed |
| Invokana | Canagliflozin | 22 | suppressed |
| Ketoconazole | Ketoconazole | 22 | suppressed |
| Colchicine | Colchicine | 21 | 15 |
| Dexlansoprazole Dr | Dexlansoprazole | 21 | suppressed |
| Lactulose | Lactulose | 21 | suppressed |
| Methimazole | Methimazole | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 19 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 19 | suppressed |
| Gemtesa | Vibegron | 19 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 11 |
| Pentoxifylline | Pentoxifylline | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | suppressed |
| Metolazone | Metolazone | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 16 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 16 | suppressed |
| Indapamide | Indapamide | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Multaq | Dronedarone Hcl | 16 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 16 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 16 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 15 | suppressed |
| Azithromycin | Azithromycin | 15 | 15 |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 15 | suppressed |
| Glucagon Emergency Kit | Glucagon | 15 | 12 |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Lacosamide | Lacosamide | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 14 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Indomethacin | Indomethacin | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 13 | suppressed |
| Benicar | Olmesartan Medoxomil | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Daptomycin | Daptomycin | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 12 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 12 | 11 |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Etodolac | Etodolac | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Nabumetone | Nabumetone | 11 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Viberzi | Eluxadoline | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $173.16 · 10 records | PFIZER INC. | Cologuard Collection Kit, ELIQUIS, FREESTYLE LIBRE 3, MOUNJARO, NURTEC ODT, REXULTI, Wegovy | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error